• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO PACIFIC PLUS; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO PACIFIC PLUS; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number UNK-CV-GWY-PCP
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Occlusion (1984); Patient Problem/Medical Problem (2688)
Event Date 06/02/2017
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During revascularization of the target lesion a pacific plus pta and four in.Pact pacific paclitaxel eluting balloon catheters were used.During a second revascularisation of the target lesion an amphirion deep pta and an in.Pact pacific paclitaxel eluting balloon catheter were used.During a third revascularization of the target lesion, an admiral xtreme pta and an in.Pact pacific paclitaxel eluting balloon catheter were used.During a fourth revascularization of the target lesion an amphirion deep pta and two in.Pact pacific paclitaxel eluting balloon catheters were used.Approximately 21 months post first revascularization, 16 months post second revascularization, 13 months post third revascularization and 8 months post fourth revascularization patient suffered re occlusion of the left sfa and popliteal (target lesion) and was treated with surgical intervention (bypass).Patient recovered.
 
Manufacturer Narrative
The surgical intervention (bypass) was performed approx 5 days post the occlusion event.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Following bypass surgery, the lesion occluded.The patient was further treated approximately five months later with deb to the left sfa.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Manufacturing site address updated.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PACIFIC PLUS
Type of Device
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
MEDTRONIC MEXICO
av.paseo del cucapah #10510
tijuana,bc 22570
MX  22570
MDR Report Key7529001
MDR Text Key108722019
Report Number3004066202-2018-00025
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
PMA/PMN Number
K123358
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup,Followup
Report Date 04/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-CV-GWY-PCP
Device Catalogue NumberUNK-CV-GWY-PCP
Was Device Available for Evaluation? No
Date Manufacturer Received11/27/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age69 YR
Patient Weight86
-
-